Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

about

Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting.Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy Altered exocrine function can drive adipose wasting in early pancreatic cancer

P2860

Q52313109-A52ECD0E-04C5-4A71-B0F4-E22F4039A235 Q57174120-A3F564D4-1352-4B6A-9DBA-75A265E4AD97 Q59071091-A778C2E0-30E1-4320-8F68-E1BE740D7599

P2860

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

Item

http://www.wikidata.org/entity/Q38653925

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

@en

type

Item

label

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

@en

prefLabel

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

@en

P1476

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

@en

P2093

Daniel L Marks

http://www.w3.org/2001/XMLSchema#string

Kevin G Burfeind

http://www.w3.org/2001/XMLSchema#string

Peter R Levasseur

http://www.w3.org/2001/XMLSchema#string

Stephanie M Krasnow

http://www.w3.org/2001/XMLSchema#string

Terry K Morgan

http://www.w3.org/2001/XMLSchema#string

Xinxia Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

C-reactive protein: a critical update

Pathophysiology of anorexia in the cancer cachexia syndrome

Cancer cachexia: mediators, signaling, and metabolic pathways

Genetically engineered mouse models of pancreatic adenocarcinoma

Cachexia and pancreatic cancer: are there treatment options?

The central role of hypothalamic inflammation in the acute illness response and cachexia

Molecular and neuroendocrine mechanisms of cancer cachexia

Current and future care of patients with the cancer anorexia-cachexia syndrome

Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats

P304

824-838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCSM.12225

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Katherine A. Michaelis

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28730707

http://www.w3.org/2001/XMLSchema#string

P932

5659050

http://www.w3.org/2001/XMLSchema#string

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

about

P2860

P2860

Establishment and characterization of a novel murine model of pancreatic cancer cachexia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932